Advantages and Disadvantages of Current Therapeutics and Phytochemicals for Age-Related Brain Disorders

Age-related brain disorders are a group of conditions characterised by the progressive loss of structure and function of neurons in the brain. These disorders primarily affect older individuals and include conditions such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, etc. Age-related brain disorders present significant challenges to individuals and healthcare professionals worldwide. Recent advancements in current therapeutics and phytochemicals play a crucial role in managing these ageing disorders of the brain. Current therapeutics have several advantages, like symptom management, modifying the underlying disease progression, established efficacy, and targeted treatment. On the other hand, it has several disadvantages, which include side effects, cost and accessibility, treatment complexity, etc. Similarly, the advantages of phytochemical usage in age-related brain disorders include that phytochemicals are derived from natural sources, they have significant antioxidant and anti-inflammatory properties, they exhibit potential neuroprotective effects, and they serve as a potential adjunct therapy. However, there is no universal standardisation or quality control, and they can interact with other medications, potentially affecting their efficacy or safety. Thus, considering the higher advantage when compared to the disadvantages regarding the current therapeutics and phytochemicals, it can be concluded that recent advancements in the treatment of age-related brain disorders provide promise for improved health care in the future. Despite these limitations, recent advancements in both current therapeutics and phytochemical research offer promise for improved management of age-related brain disorders in the future. Further studies are crucial to fully understand the mechanisms of action of phytochemicals, establish optimal dosages, and develop standardized extracts to ensure consistent clinical outcomes.